Stockreport

Eagle Pharmaceuticals Announces Laboratory Test Results Demonstrating In Vitro Antiviral Activity of RYANODEX® (dantrolene sodium) Against Coronavirus SARS-CoV-2

Eagle Pharmaceuticals, Inc.  (EGRX) 
Last eagle pharmaceuticals, inc. earnings: 3/2 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: investor.eagleus.com
PDF IND Submitted to FDA for Planned Clinical Study at Hackensack University Medical Center to Evaluate RYANODEX for Treatment of COVID-19 Patients WOODCLIFF LAKE, N.J.-- [Read more]